Bilaketaren emaitzak - Filip Moerman
- Erakusten 1 - 2 emaitzak -- 2
-
1
HIV‐1 Immune Suppression and Antimalarial Treatment Outcome in Zambian Adults with Uncomplicated Malaria nork Jean‐Pierre Van Geertruyden, Modest Mulenga, Lawrence Mwananyanda, Victor Chalwe, Filip Moerman, Roma Chilengi, Webster Kasongo, Chantal Van Overmeir, Jean‐Claude Dujardin, Robert Colebunders, Luc Kestens, Umberto D’Alessandro
Argitaratua 2006Artigo -
2
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial nork Jozefien Declercq, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cédric Bosteels, Simon J. Tavernier, Stefanie De Buyser, Roos Colman, Maya Hites, Gil Verschelden, Tom Fivez, Filip Moerman, Ingel Demedts, Nicolás Dauby, Nicolas De Schryver, Elke Govaerts, Stefaan J. Vandecasteele, Johan Van Laethem, Sébastien Anguille, Jeroen C.H. van der Hilst, Benoît Misset, Hans Slabbynck, Xavier Wittebole, F Liénart, Catherine Legrand, Marc Buyse, Dieter Stevens, F Bauters, Leen Seys, Helena Aegerter, Ursula Smole, Victor Bosteels, Levi Hoste, Leslie Naesens, Filomeen Haerynck, Linos Vandekerckhove, Pieter Depuydt, Eva Van Braeckel, Sylvie Rottey, Isabelle Peene, Catherine Van Der Straeten, Frank Hulstaert, Bart N. Lambrecht
Argitaratua 2021Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Immunology
Internal medicine
Medicine
Virology
2019-20 coronavirus outbreak
Betacoronavirus
Clinical trial
Confidence interval
Coronavirus disease 2019 (COVID-19)
Cytokine
Cytokine release syndrome
Disease
Infectious disease (medical specialty)
Interleukin
Interleukin 6
Malaria
Outbreak
Parasitemia
Pharmacology
Plasmodium falciparum
Randomized controlled trial
Relative risk
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)